Granted through the small business waiver provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the waiver will ...

Mr. Patel brings more than two decades of legal and compliance leadership in the pharmaceutical industry, having advised companies across every stage of drug development, launch, and commercialization ...

We came across a bullish thesis on Cencora, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize ...

Shivam Enterprise, a trusted name in the pharmaceutical industry for over two decades, is all set to expand its horizons with ...

Management lowered full-year FY2025 guidance and highlighted continued cost savings and portfolio optimization, with muted growth expected in the near term. These 10 stocks could mint the next wave of ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

Mr. Patel brings more than two decades of legal and compliance leadership in the pharmaceutical industry, having advised companies across every stage of drug development, launch, and commercialization ...

Experts Reveal 2025 Dog Gut Health Findings, Ingredient Transparency Push, and the Rise of Targeted Canine ProbioticsNew York, Aug. 02, 2025 (GLOB ...

On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing on ...

ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer's type in adults. As a new generation of ...